Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWEAR: Switch to TDF/FTC/RPV vs Continue TDF/FTC/EFV
NCT02042001Phase 4Completed
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Fondazione IRCCS San Gerardo dei Tintori. Started Jul 2015; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02042001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042001.